Literature DB >> 11384684

Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries.

J Lou1, R Marzari, V Verzillo, F Ferrero, D Pak, M Sheng, C Yang, D Sblattero, A Bradbury.   

Abstract

Antibodies against most antigens can be isolated from high quality phage antibody libraries. However, not all antibodies binding a particular antigen are necessarily found when standard selections are performed. Here we investigate the effect of two different selection strategies on the isolation of antibodies against a number of different antigens, and find that these different strategies tend to select different antibodies, with little overlap between them. This indicates that the full diversity of these libraries is not tapped by a single selection strategy and that each selection strategy imposes different selective criteria in addition to that of antigen binding. To fully exploit such libraries, therefore, many different selection strategies should probably be employed for each antigen. The use of alternative strategies should be considered when selection apparently fails, or when the number of different antibodies recognizing an antigen needs to be maximised. Furthermore, the microtitre selection strategy developed is likely to prove useful in the application of phage antibody libraries to the human genome project, allowing the high throughput selection of antibodies against multiple antigens simultaneously.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384684     DOI: 10.1016/s0022-1759(01)00385-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  15 in total

1.  Recombinant single-chain Fv antibodies that recognize the p25 protein of the Maedi-Visna virus.

Authors:  V Celer; D Blazek; I Navrátilová; P Skládal; B Blacklaws; R Bujdoso
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

2.  A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope.

Authors:  Michael D Miller; Romas Geleziunas; Elisabetta Bianchi; Simon Lennard; Renee Hrin; Hangchun Zhang; Meiqing Lu; Zhiqiang An; Paolo Ingallinella; Marco Finotto; Marco Mattu; Adam C Finnefrock; David Bramhill; James Cook; Debra M Eckert; Richard Hampton; Mayuri Patel; Stephen Jarantow; Joseph Joyce; Gennaro Ciliberto; Riccardo Cortese; Ping Lu; William Strohl; William Schleif; Michael McElhaugh; Steven Lane; Christopher Lloyd; David Lowe; Jane Osbourn; Tristan Vaughan; Emilio Emini; Gaetano Barbato; Peter S Kim; Daria J Hazuda; John W Shiver; Antonello Pessi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

3.  Large scale production of phage antibody libraries using a bioreactor.

Authors:  Fortunato Ferrara; Chang-Yub Kim; Leslie A Naranjo; Andrew R M Bradbury
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 4.  Rationalizing Random Walks: Replicating Protective Antibody Trajectories.

Authors:  Jennifer L Remmel; Margaret E Ackerman
Journal:  Trends Immunol       Date:  2021-01-26       Impact factor: 16.687

5.  Identification of novel proteins binding the AU-rich element of α-prothymosin mRNA through the selection of open reading frames (RIDome).

Authors:  Laura Patrucco; Clelia Peano; Andrea Chiesa; Filomena Guida; Imma Luisi; Ilenia Boria; Flavio Mignone; Gianluca De Bellis; Silvia Zucchelli; Stefano Gustincich; Claudio Santoro; Daniele Sblattero; Diego Cotella
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

6.  Rapid interactome profiling by massive sequencing.

Authors:  Roberto Di Niro; Ana-Marija Sulic; Flavio Mignone; Sara D'Angelo; Roberta Bordoni; Michele Iacono; Roberto Marzari; Tiziano Gaiotto; Miha Lavric; Andrew R M Bradbury; Luigi Biancone; Dina Zevin-Sonkin; Gianluca De Bellis; Claudio Santoro; Daniele Sblattero
Journal:  Nucleic Acids Res       Date:  2010-02-09       Impact factor: 16.971

7.  Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism.

Authors:  Claire L Dobson; Sarah Main; Philip Newton; Matthieu Chodorge; Karen Cadwallader; Robin Humphreys; Vivian Albert; Tristan J Vaughan; Ralph R Minter; Bryan M Edwards
Journal:  MAbs       Date:  2009-11-11       Impact factor: 5.857

8.  Beyond natural antibodies: the power of in vitro display technologies.

Authors:  Andrew R M Bradbury; Sachdev Sidhu; Stefan Dübel; John McCafferty
Journal:  Nat Biotechnol       Date:  2011-03       Impact factor: 54.908

9.  Development of phage-based single chain Fv antibody reagents for detection of Yersinia pestis.

Authors:  Antonietta M Lillo; Joanne E Ayriss; Yulin Shou; Steven W Graves; Andrew R M Bradbury; Peter Pavlik
Journal:  PLoS One       Date:  2011-12-08       Impact factor: 3.240

10.  Oligonucleotide-assisted cleavage and ligation: a novel directional DNA cloning technology to capture cDNAs. Application in the construction of a human immune antibody phage-display library.

Authors:  Sonia Schoonbroodt; Nicolas Frans; Mark DeSouza; Rachel Eren; Smadar Priel; Naama Brosh; Judith Ben-Porath; Arie Zauberman; Ehud Ilan; Shlomo Dagan; Edward H Cohen; Hennie R Hoogenboom; Robert Charles Ladner; René M Hoet
Journal:  Nucleic Acids Res       Date:  2005-05-19       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.